In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Ambit Biosciences Announces Drug Screening Collaboration with Bristol-Myers Squibb
Bristol-Myers Squibb Announces Completion of ConvaTec Divestiture
BRISTOL-MYERS SQUIBB TO ACQUIRE ADNEXUS THERAPEUTICS
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Nerviano Medical Sciences announces agreement with Bristol-Myers Squibb to deliver oncology ECNs
Bristol-Myers Squibb to Acquire Medarex
MorphoSys AG Announces Expanded Agreement With Bristol-Myers Squibb on Use of HuCAL GOLD®
Virologic enters collaborative agreement with Bristol-Myers Squibb